LABORATORY INVESTIGATION REPORT
Patient Name : Mr. DEEPAK KUMAR AGARWAL . Age/Sex : 65Year(s) / Male
UHID : AIGG.20017784 Order Date : 03-05-2025 14:33
Episode : OP
Ref. Doctor : Dr.NILKANTH C PATIL Mobile No : 918249210874
Facility : AIG Hospitals, Gachibowli
ABHA : ABHA Address :
Biochemistry
TEST RESULT UNIT BIOLOGICAL REF INTERVAL
Sample No : AGH1060285F Collection Date : 03/05/25 15:17 Ack Date : 03/05/2025 15:51 Report Date : 03/05/25 16:56
LIPID PROFILE
Sample- Serum
TOTAL CHOLESTEROL 117 mg/dL <200
Method - CHO-POD
HDL CHOLESTEROL 36 ▼ (L) mg/dL 40 - 60
Method - ENZYMATIC COLORIMETRIC
VLDL CHOLESTEROL 16 mg/dL 2 - 30
Method - CALUCLATED
DIRECT LDL CHOLESTEROL 65 mg/dL <100
Method - Calculated
NON-HDL CHOLESTEROL 81 mg/dL <120
Method - Calculated
TRIGLYCERIDES 78 mg/dL Less than 150
Normal 150-199
Borderline High
200-499 High >500
Very High
Method - GPO POD
TOTAL CHOLESTEROL / HDL RATIO 3.3 - <3.5
Method - Calculated
TG / HDL RATIO 2.2 ▲ (H) - <2.0
Method - Calculated
Page 1 of 3
LABORATORY INVESTIGATION REPORT
Patient Name : Mr. DEEPAK KUMAR AGARWAL . Age/Sex : 65Year(s) / Male
UHID : AIGG.20017784 Order Date : 03-05-2025 14:33
Episode : OP
Ref. Doctor : Dr.NILKANTH C PATIL Mobile No : 918249210874
Facility : AIG Hospitals, Gachibowli
ABHA : ABHA Address :
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _
| NCEP- ATP III | TOTAL CHOLESTEROL | TRIGLYCERIDE | LDL CHOLESTEROL | NO HDL CHOLESTEROL .
| (Recommendations) | (in mg/dL) | (in mg/dL) | (in mg/dL) . | . (in mg/dL) |
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _
| Optimal | <200 | <150 | <100 .. | <130 |
| Above Optimal | - | - | 100-129 .. | 130-159 |
| Borderline High | 200-239 | 150-199 | 130-159 .. |160 - 189 |
| High | >=240 | 200-499 | 160-189 .. |190 - 219 |
| Very High | - | >=500 | >=190 .. | >=220 |
| _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _
| HDL Cholestrol |
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _
| <40 | Low |
| >60 | High |
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _
.
For Adult & Children
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _ __ _ _ _ __ _ _ _ ___
| | Total Cholesterol/HDL Ratio | TG/HDL |
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _ __ _ _ _ __ _ _ _ __ _
| Optimal | <3.5 | <2.0 |
| Moderate | 3.5 - 5.0 | 2 - 3.8 |
| High | >5.0 | >3.8 |
_ _ _ __ _ _ _ __ _ _ _ __ _ _ _ __ _ _ _ _ __ _ _ _ __ _ _ _ ___ _
Interpretations_ _ _ :
1. All above biological reference intervals/ranges are in accordance to the recommendations of The National Cholesterol Education
Program(NCEP) Adult Treatment Panel III (ATP III) Guidelines providing the most desirable targets of various circulating lipid fractions in the
blood. Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous
interpretation. NCEP recommends the assessment of 3 different samples drawn at intervals of 1 week for harmonizing biological variables
that might be encountered in single assays.
2. Low HDL levels are associated with increased risk forAtherosclerotic Cardiovascular disease (ASCVD) due to insufficient HDL being
available to participate in reverse cholesterol transport, the process by which cholesterol is eliminated from peripheral tissues.
3. NLA-2014identifies Non HDL Cholesterol (an indicator of all atherogeniclipoproteins such as LDL , VLDL, IDL, Lpa, Chylomicron
remnants)along with LDL-cholesterol as co- primary target for cholesterol lowering therapy. Note that major risk factors can modify
treatment goals for LDL &Non HDL.
4. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have been achieved.
5. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients with moderate risk for ASCVD for
risk refinement.
Fried Ewald Equation is not applicable for calculation of LDL & VLDL. Hence the calculated values are not provided for such samples.
Cautions:
Report Saved By - Dr.Mahavadi Srihita (03/05/2025 16:56 PM)
Page 2 of 3
LABORATORY INVESTIGATION REPORT
Patient Name : Mr. DEEPAK KUMAR AGARWAL . Age/Sex : 65Year(s) / Male
UHID : AIGG.20017784 Order Date : 03-05-2025 14:33
Episode : OP
Ref. Doctor : Dr.NILKANTH C PATIL Mobile No : 918249210874
Facility : AIG Hospitals, Gachibowli
ABHA : ABHA Address :
End of Report
Dr.Mahavadi Srihita
Consultant Biochemistry
RegNo: APMC/FMR/94112
Page 3 of 3
